Highlights and Quick Summary
- EBT for the quarter ending June 30, 2023 was $-64.9 Million (a 46.88% increase compared to previous quarter)
- Year-over-year quarterly EBT increased by 56.82%
- Annual EBT for 2022 was $-168 Million (a 12.6% increase from previous year)
- Annual EBT for 2021 was $-149 Million (a 151.18% increase from previous year)
- Annual EBT for 2020 was $-59.4 Million (a 300.01% increase from previous year)
- Twelve month EBT ending June 30, 2023 was $-189 Million (a 7.13% increase compared to previous quarter)
- Twelve month trailing EBT increased by 4.55% year-over-year
Trailing EBT for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-189 Million | $-177 Million | $-168 Million | $-181 Million |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT of Dyne Therapeutics, Inc.
Most recent EBTof DYN including historical data for past 10 years.Interactive Chart of EBT of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. EBT for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-64.9 | $-44.19 | – | – | – |
| 2022 | $-38.83 | $-41.39 | $-52.3 | $-35.58 | $-168.1 |
| 2021 | $-51.79 | $-42.58 | $-29.96 | $-24.97 | $-149.29 |
| 2020 | $-28.65 | $-13.92 | $-8.98 | $-7.89 | $-59.44 |
| 2019 | – | – | – | $-5.87 | $-14.86 |
| 2018 | – | – | – | – | $-4.81 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology